GRK2/β-arrestin mediates arginine vasopressin-induced cardiac fibroblast proliferation
Author:
Affiliation:
1. Department of Pharmacology; Nantong University School of Pharmacy; Nantong China
2. Department of Pharmacology; School of Life Sciences and Biopharmaceutics; Shenyang Pharmaceutical University; Shenyang China
Funder
National Natural Science Foundation of China
Nantong University Co-Innovation Program
Publisher
Wiley
Subject
Physiology (medical),Pharmacology,Physiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12696/fullpdf
Reference36 articles.
1. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure;Brown;Ann Rev Pharmacol Toxicol,2005
2. Cardiac fibroblasts: at the heart of myocardial remodeling;Porter;Pharmacol Ther,2009
3. Cloning and characterization of the human V3 pituitary vasopressin receptor;Keyzer;FEBS Lett,1994
4. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus;Lolait;Nature,1992
5. Molecular cloning and expression of a rat V1a arginine vasopressin receptor;Morel;Nature,1992
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression;International Journal of Molecular Sciences;2023-12-08
2. Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway;Aging;2023-10-09
3. Gender differences in GRK2 in cardiovascular diseases and its interactions with estrogen;American Journal of Physiology-Cell Physiology;2023-02-01
4. PGE2 protects against heart failure through inhibiting TGF-β1 synthesis in cardiomyocytes and crosstalk between TGF-β1 and GRK2;Journal of Molecular and Cellular Cardiology;2022-11
5. G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases;Frontiers in Immunology;2022-01-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3